Skip to content

MMSX

Active
Private limited company·Veterinaire diensten· 4 yrs active
Den Brem 60 ·2610 Antwerpen, Belgium
KBO/BCE: BE 0786.556.964
Watch Print / PDF
Age4 yrs
Connections2

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of MMSX is 0.1% (very low). The 2024 annual accounts show equity of €67k and a net result of €23k. Equity is growing by ~71.7% per year across the filed fiscal years. Its solvency ranks better than 92% of 556 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 3 annual accounts.

Signals

3 signals · with evidence
Strong solvency vs sector
Solvency is in the sector's strongest quartile: better than 92% of 556 peers (2024). A comfortable equity buffer.
View the sector comparison
Consistently profitable
Positive net result in the two most recent financial years (2023 and 2024).
View the result trend
Growing equity
Equity grew over 2022-2024. Profits are largely retained rather than distributed.
View the equity trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Deadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 10 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 22-07-2025, 9 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
How we compute the deadline
The year end is derived from 3 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 nothing on record not filed -
31-12-2024 31-07-2025 22-07-2025 9 d early 2025-00293035
31-12-2023 31-07-2024 31-07-2024 on the day 2024-00310786
31-12-2022 31-07-2023 25-07-2023 6 d early 2023-00267117

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2022, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.1% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€23k-42.9%
Working capital€68k+55.3%

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 22-07-2025 with the NBB · fiscal year 2024 · micro
€0€20k€40k€60kOperating result 2022: €3k€3kNet result 2022: €2k€2kOperating result 2023: €51k€51kNet result 2023: €40k€40kOperating result 2024: €31k€31kNet result 2024: €23k€23k202220232024
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~71.7%/year over 3 fiscal years, indicative, assuming unchanged policy.
€0€50k€100k€150k2025: €98k (€93k - €104k)2026: €130k (€124k - €135k)2027: €161k (€156k - €167k)2022: €4k2023: €44k2024: €67k202220232024202520262027
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2024 · NACE 75 · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 87.0% 49.2%
better than 92% of 556 sector peers
Net result €23k €25k
better than 47% of 556 sector peers
Equity €67k €55k
better than 56% of 556 sector peers
Gross operating margin €33k €52k
better than 33% of 556 sector peers
Total assets €77k €136k
better than 30% of 556 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P92
2022: P20 · n=3332023: P75 · n=4522024: P92 · n=5562022 2024
Improving position over 2022-2024 · n=333-556
Net result P47
2022: P16 · n=3332023: P71 · n=4522024: P47 · n=5562022 2024
Improving position over 2022-2024 · n=333-556
Equity P56
2022: P12 · n=3332023: P47 · n=4522024: P56 · n=5562022 2024
Improving position over 2022-2024 · n=333-556
Gross operating margin P33
2022: P9 · n=3332023: P55 · n=4522024: P33 · n=5562022 2024
Improving position over 2022-2024 · n=333-556
Describes the position versus peers, not a forecast.
EBITDA
€31k
-39.5% 22-24
Net profit
€23k
-42.9% 22-24
Cash flow
€23k
-42.4% 22-24
Total assets
€77k
+14.6% 22-24
Equity
€67k
+52.1% 22-24
Working capital
€68k
+55.3% 22-24
Income taxes
€7k
-35.7% 22-24
Debt
€10k
-56.7% 22-24
Debt ≤ 1y
€9k
-61.5% 22-24
Current ratio
8.81
+199.9% 22-24
Quick ratio
8.81
+199.9% 22-24
Solvency
87.0%
+32.7% 22-24
Debt / equity
0.15
-71.5% 22-24
ROE
34.2%
-62.5% 22-24
ROA
29.8%
-50.2% 22-24
Interest coverage
31.01
-96.8% 22-24
Figures by fiscal year
Fiscal year2024
Depositmicro
Revenue-
EBITDA€31k
Net profit€23k
Cash flow€23k
Staff costs-
Income taxes€7k
Dividends-
Total assets€77k
Equity€67k
Debt€10k
of which ≤ 1y€9k
of which > 1y-
Working capital€68k
Employees (FTE)-
Ratios (computed)
2024
Current ratio8.81
Quick ratio8.81
Working capital ratio88.1%
Solvency87.0%
Debt / equity0.15
Long-term debt ratio-
Interest coverage31.01
Gross margin-
Net margin-
ROA29.8%
ROE34.2%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€77k
Fixed assets 21/28€506
Tangible fixed assets 22/27€506
Current assets 29/58€76k
Amounts receivable within one year 40/41€5k
Cash & bank 54/58€70k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€77k
Equity 10/15€67k
Contributions / capital 10/11€2k
Reserves 13€65k
Amounts payable 17/49€10k
Amounts payable within one year 42/48€9k
Trade debts payable within one year 44€867
Income statement
Gross operating margin 9900€33k
Operating result 9901€31k
Financial income 75€243
Financial charges 65€1k
Result before taxes 9903€30k
Income taxes 67/77€7k
Net result for the period 9904€23k
Result to be appropriated 9905€23k
You're seeing the latest fiscal year only. Unlock 2 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
93 / 100 Excellent
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Structure & network

Connections & network

2 connected companies
Group structure
DIERENKLINIEK DE BOSDREEF
Subsidiary · 2 locations
Dierenkliniek De Morette
Subsidiary · 1 location
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.

Locations & real estate

Establishment units

1 location
MMSX
Den Brem 60, 2610 AntwerpenVeterinaire diensten
since 20222.331.983.631
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area1,565 m²
Buildings1
Building footprint177 m²
Volume (LiDAR)849 m³
Tallest building7.9 m · ±2 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11462A0064/00X000 Flanders 1,565 m² 1 · 177 m² 7.9 m · 2 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgian State Gazette · acts

No structured acts for this company yet

That means one of two things: the company has published no company deeds, or its deeds are still queued for reading. The insolvency signals above come from a separate source and are complete.

Analysis

Snowflake analysis

financial profile on 5 axes
Health93Profitability100Solvency100Growth78Stability94
93 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 93
Profitability 100
Solvency 100
Growth 78
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector, ranked by comparable size

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Veterinaire diensten75000Veterinaire diensten75000
Primary activity highlighted.
Names & trade names
Legal nameNL MMSX
Registered office
Den Brem 60
2610 Antwerpen, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.